Résultats de recherche pour « Latent Space Hypothesis »

Drug discovery relies on iterative expert workflows that are slow to parallelize and difficult to scale. Here we introduce Latent-Y, an AI agent that autonomously executes complete antibody design campaigns from text prompts, covering literature review, target analysis, epitope identification, candidate design, computational validation, and selection of lab-ready sequences. Latent-Y is integrated into the Latent Labs Platform, where it operates in the same environment as drug-discovery experts with access to bioinformatics tools, biological databases, and scientific literature. The agent can run fully autonomously end-to-end, or collaboratively, where researchers review progress, provide feedback, and direct subsequent steps. Candidate antibodies are generated using Latent-X2, our frontier generative model for drug-like antibody design. We demonstrate the agent's capability across three distinct campaign types: epitope discovery guided by therapeutic specifications, cross-species binder design, and autonomous design from a scientific publication targeting human transferrin receptor for blood-brain barrier crossing. Across nine targets, Latent-Y produced lab-confirmed nanobody binders against six, achieving a 67% target-level success rate with binding affinities reaching the single-digit nanomolar range, without human filtering or intervention. In user studies, experts working with Latent-Y completed design campaigns 56 times faster than independent expert time estimates, compressing weeks of work into hours. Because Latent-X2 is a general-purpose atomic-level model for biologics design, the same agent architecture naturally extends to macrocyclic peptide and mini-binder design campaigns, broadening autonomous discovery across therapeutic modalities. Latent-Y is available to selected partners at https://platform.latentlabs.com.

Traditional drug discovery relies on rounds of screening millions of candidate molecules with low success rates, making drug discovery time and resource intensive. To overcome this screening bottleneck, we introduce Latent-X, an all-atom protein design model that enables a new paradigm of precision AI design. Given a target protein epitope, Latent-X jointly generates the all atom structure and sequence of the protein binder and target, directly modelling the non-covalent interactions essential for specific binding. We demonstrate its efficacy across two therapeutically relevant modalities through extensive wet lab experiments, testing as few as 30-100 designs per target. For macrocyclic peptides, Latent-X achieves experimental hit rates exceeding 90% on all evaluated benchmark targets. For mini-binders, it consistently produces potent candidates against all evaluated benchmark targets, with binding affinities reaching the low nanomolar and picomolar range - comparable to those of approved therapeutics - whilst also being highly specific in mammalian display. In direct comparisons with the state-of-the-art models AlphaProteo, RFdiffusion and RFpeptides under identical conditions demonstrates, Latent-X generates binders with higher hit rates and better binding affinities, and uniquely creates structurally diverse binders, including complex beta-sheet folds. Its end-to-end process is an order of magnitude faster than existing multi-step computational pipelines. By drastically improving the efficiency and success rate of de novo design, Latent-X represents a significant advance towards push-button biologics discovery and a valuable tool for protein engineers. Latent-X is available at https://platform.latentlabs.com, enabling users to reliably generate de novo binders without AI infrastructure or coding.

Artificial intelligence is a powerful tool that could be deployed to accelerate the scientific enterprise. Here we address a major unmet need: use of existing scientific literature to generate novel hypotheses. We use a deep symmetry between the fields of neuroscience and developmental bioelectricity to test a tool, FieldSHIFT, that generates scientific text from existing published studies. We show how this system helps human scientists explore a latent space of papers that could exist, which provides a rich field of suggested future research. We then test a key prediction of this model using bioinformatics, showing a surprising conservation of molecular mechanisms involved in cognitive behavior and developmental morphogenesis. By allowing scientists to rapidly explore symmetries and meta-parameters that exist in a corpus of scientific papers, we show how machine learning can potentiate human creativity and assist with one of the most interesting and crucial aspects of research: identifying insights from data and generating potential candidates for research agendas.

Drug discovery has long sought computational systems capable of designing drug-like molecules directly: developable and non-immunogenic from the start. Here we introduce Latent-X2, a frontier generative model that achieves this goal through zero-shot design of antibodies with strong binding affinities, drug-like properties, and, for the first time for any de novo generated antibody, confirmed low immunogenicity in human donor panels. Latent-X2 is an all-atom model conditioned on target structure, epitope specification, and optional antibody framework, jointly generating sequences and structures while modelling the bound complex. Testing only 4 to 24 designs per target in each modality, we successfully generated VHH and scFv antibodies against 9 of 18 evaluated targets, achieving a 50% target-level success rate with picomolar to nanomolar binding affinities. Designed molecules exhibit developability profiles that match or exceed those of approved antibody therapeutics, including expression yield, aggregation propensity, polyreactivity, hydrophobicity, and thermal stability, without optimization, filtering, or selection. In the first immunogenicity assessment of any AI-generated antibody, representative de novo VHH binders targeting TNFL9 exhibit both potent target engagement and low immunogenicity across T-cell proliferation and cytokine release assays. The model generalizes beyond antibodies: against K-Ras, long considered undruggable, we generated macrocyclic peptide binders competitive with trillion-scale mRNA display screens. These properties emerge directly from the model, demonstrating the therapeutic viability of zero-shot molecular design, now available without AI infrastructure or coding expertise at https://platform.latentlabs.com.

Medical data range from genomic sequences and retinal photographs to structured laboratory results and unstructured clinical narratives. Although these modalities appear disparate, many encode convergent information about a single underlying physiological state. The Latent Space Hypothesis frames each observation as a projection of a unified, hierarchically organized manifold -- much like shadows cast by the same three-dimensional object. Within this learned geometric representation, an individual's health status occupies a point, disease progression traces a trajectory, and therapeutic intervention corresponds to a directed vector. Interpreting heterogeneous evidence in a shared space provides a principled way to re-examine eponymous conditions -- such as Parkinson's or Crohn's -- that often mask multiple pathophysiological entities and involve broader anatomical domains than once believed. By revealing sub-trajectories and patient-specific directions of change, the framework supplies a quantitative rationale for personalised diagnosis, longitudinal monitoring, and tailored treatment, moving clinical practice away from grouping by potentially misleading labels toward navigation of each person's unique trajectory. Challenges remain -- bias amplification, data scarcity for rare disorders, privacy, and the correlation-causation divide -- but scale-aware encoders, continual learning on longitudinal data streams, and perturbation-based validation offer plausible paths forward.

<p>Computational design tools enable designers to construct and manipulate representations of design artifacts to arrive at a solution. However, the constraints of deterministic programming impose a high cost of tedium and inflexibility to exploring design alternatives through these models. They require designers to express high-level design intent through sequences of low-level operations. Generative neural networks are able to construct generalised models of images which capture principles implicit within them. The latent spaces of these models can be sampled to create novel images and to perform semantic operations. This presents the opportunity for more meaningful and efficient design experimentation, where designers are able to express design intent through principles inferred by the model, instead of sequences of low-level operations. A general purpose software prototype has been devised and evaluated to investigate the affordances of such a tool. This software — termed a SpaceSheet — takes the form of a spreadsheet interface and enables users to explore a latent space of fonts. User testing and observation of task-based evaluations revealed that the tool enabled a novel top-down approach to design experimentation. This mode of working required a new set of skills for users to derive meaning and navigate within the model effectively. Despite this, a rudimentary understanding was observed to be sufficient to enable designers and non-designers alike to explore design possibilities more effectively.</p>

We propose an end-to-end trained neural networkarchitecture to robustly predict the complex dynamics of fluid flows with high temporal stability. We focus on single-phase smoke simulations in 2D and 3D based on the incompressible Navier-Stokes (NS) equations, which are relevant for a wide range of practical problems. To achieve stable predictions for long-term flow sequences, a convolutional neural network (CNN) is trained for spatial compression in combination with a temporal prediction network that consists of stacked Long Short-Term Memory (LSTM) layers. Our core contribution is a novel latent space subdivision (LSS) to separate the respective input quantities into individual parts of the encoded latent space domain. This allows to distinctively alter the encoded quantities without interfering with the remaining latent space values and hence maximizes external control. By selectively overwriting parts of the predicted latent space points, our proposed method is capable to robustly predict long-term sequences of complex physics problems. In addition, we highlight the benefits of a recurrent training on the latent space creation, which is performed by the spatial compression network.